2026 data FDA MAUDE openFDA FDA Class II

Enzyme Immunoassay, Digoxin

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA Class II (moderate risk, special controls required), regulated under 21 CFR §862.3320 (Clinical Toxicology panel).

FDA MAUDE casebook

openFDA event book Enzyme Immunoassay, Digoxin LIGHT-BOOK · MAUDE

#908 of 1000 · 478 reports · 1994–2026

  • BOOK 478 reports
  • RANK #908 of 1000
  • DEATH 1 death-typed
  • INJ 5 injury-typed
  • MALF 462 malfunction
  • SPAN 1994–2026
  • PEAK 2007: 310
  • PHOTO Scaffold

Nearest event-volume peer: Scaffold, Dissection Repair (0 report gap)

Enzyme Immunoassay, Digoxin sits #908 of 1000 among tracked device types with 478 MAUDE reports spanning 1994–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Malfunction reports run above the device-type norm

Enzyme Immunoassay, Digoxin carries 96.7% MALFUNCTION-coded reports, 31.8pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 0.2% corpus 1.5% · below corpus mean (-1.3 pp)
  • INJ 1.0% corpus 30.3% · below corpus mean (-29.2 pp)
  • MALF 96.7% corpus 64.8% · above corpus mean (+31.8 pp)

Lead product-problem code Device Displays Incorrect Message is 48% of coded problems · Lead manufacturer ROCHE DIAGNOSTICS accounts for 37% of manufacturer-tagged reports · Top event location is 89% of location-tagged rows .

Enzyme Immunoassay, Digoxin in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Enzyme Immunoassay, Digoxin carries 478 MAUDE reports, ranked #908 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 462 (96.7%)
Other 9 (1.9%)
Injury 5 (1.0%)
1 (0.2%)
Death 1 (0.2%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

461 (96.4%)
Other 14 (2.9%)
Required Intervention 2 (0.4%)
Death 1 (0.2%)

Top Product Problems

Device Displays Incorrect Message 252
Incorrect Or Inadequate Test Results 88
High Test Results 60
Low Test Results 59
Calibration Problem 14
Incorrect, Inadequate or Imprecise Result or Readings 13
Nonstandard Device 8
False Positive Result 4
Malfunction 4
Adverse Event Without Identified Device or Use Problem 3
Calibration Error 3
False Reading From Device Non-Compliance 3
Non Reproducible Results 3
Contamination 2
Incorrect Measurement 2
Unexpected Therapeutic Results 2
Alarm, failure of warning 1
Component Falling 1
Detachment Of Device Component 1
Failure, intermittent 1

Yearly Trend

94
1994: 1
96
1996: 1
97
1997: 3
99
1999: 4
01
2001: 1
02
2002: 2
04
2004: 1
05
2005: 2
07
2007: 310
08
2008: 6
09
2009: 9
10
2010: 11
11
2011: 19
12
2012: 15
13
2013: 39
14
2014: 7
15
2015: 1
16
2016: 4
17
2017: 19
18
2018: 1
20
2020: 5
21
2021: 1
22
2022: 3
23
2023: 4
24
2024: 7
26
2026: 2

Reports rose to 7 in 2024, up from an average of 4 in the two years before - a recent-year increase, not a lifetime pattern.

Related Entities for Enzyme Immunoassay, Digoxin

Event Locations

424 (88.7%)
I 30 (6.3%)
LABORATORY 14 (2.9%)
OTHER 5 (1.0%)
HOSPITAL 2 (0.4%)
INVALID DATA 2 (0.4%)
NOT APPLICABLE 1 (0.2%)

Compare ROCHE DIAGNOSTICS vs SIEMENS HEALTHCARE DIAGNOSTICS INC →

Nationwide devices with a comparable volume-and-death footprint

Two openFDA-derived peer sets for Enzyme Immunoassay, Digoxin: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (478 here).

Similar death-typed counts

Nearest other device types by death-typed report count (1 here), distinct from the volume row.

Disclaimer: MAUDE figures for Enzyme Immunoassay, Digoxin are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Enzyme Immunoassay, Digoxin; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.